PMRA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pharma Mar SA

Watchlist Manager

Watchlist

Price: 83.85 EUR -0.12% Market Closed

Market Cap: €1.5B

	Pharma Mar SA F:PMRA	ES
	Blue Line Protection Group Inc OTC:BLPG	US
	Born Inc OTC:BRRN	US
B	Birchcliff Energy Ltd XBER:39B	CA
	Beam Communications Holdings Ltd ASX:BCC	AU
S	Shield Therapeutics PLC SWB:1JS	UK
	CyberFuels Holding Company Inc OTC:CBRF	US
T	TaiMed Biologics Inc TPEX:4147	TW

Profitability Summary

Pharma Mar SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

94%

Gross Margin is Increasing

93% > 93%

Healthy Operating Margin

18%

Low 3Y Average Operating Margin

Operating Margin is Increasing

7% > 18%

Healthy Net Margin

26%

Sustainable 3Y Average Net Margin

14%

Net Margin is Increasing

12% > 26%

Exceptional Free Cash Flow Margin

23%

Negative 3Y Average Free Cash Flow Margin

-2%

Free Cash Flow Margin is Increasing

-8% > 23%

Positive ROE

25%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

87%

ROIC is Increasing

17% > 31%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.